In continuation to the outcome of the board meeting regarding appointment of S. Phani Srinath as Chief Financial Officer (CFO) of the company based on the recommendations of the Audit and Nomination and Remuneration Committees, vide the letter dated 10th September 2018, Krebs Biochemicals & Industries has informed about a brief profile of S. Phani Srinath as required under the Listing Regulations.
The above information is a part of company’s filings submitted to BSE.